This has been well studied in hypertension, where blocking the conversion of AA-derived EETs to DHETs using specific sEH inhibitors in animal and human studies had a significant effect on lowering blood pressure [32,33,36,37]. Here, EPHX2 is linked to hypertensive disorder.